| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | United States | 5 | |
| #3 | Australia | 1 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chadeayne Andrew R | 6 |
| #2 | Chedeayne Andrew | 5 |
| #3 | Chadeayne Andrew | 3 |
| #4 | Andrew R Chedeayne | 1 |
| #5 | Chedeayne Andrew R | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2021085671A1 | Compositions and methods comprising a combination of serotonergic drugs | |
| WO2021076849A1 | New kratom compositions | |
| WO2021041407A1 | Alkyl quarternary ammonium tryptamines and their therapeutic uses | |
| US2021023052A1 | Compositions containing toad secretion compounds | |
| WO2020263941A1 | Ibogaine formulations | |
| US2019142851A1 | Compositions comprising a psilocybin derivative and a cannabinoid | |
| CA3052974A1 | Compositions and methods comprising a psilocybin derivative |